AIM ImmunoTech Inc. (AIM)
AMEX: AIM
· Real-Time Price · USD
2.52
-0.05 (-1.95%)
At close: Aug 15, 2025, 3:58 PM
2.65
5.16%
After-hours: Aug 15, 2025, 07:30 PM EDT
AIM ImmunoTech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 16K | 45K | 35K | 50K | 40K | 65K | 46K | 42K | 49K | 56K | 21K | 30K | 33K | 50K | 33K | 23K | 28K |
Cost of Revenue | 10K | 7K | 8K | 8K | 66K | 70K | 30K | 91K | 84K | n/a | 6.52M | 69K | 77K | 176K | 157K | 279K | 237K |
Gross Profit | 6K | 38K | 27K | 42K | -26K | -5K | 16K | -49K | -35K | 56K | -6.5M | -39K | -44K | -126K | -124K | -256K | -209K |
Operating Income | -3.62M | 13.92M | -4.49M | -3.69M | -5.73M | -13.99M | -7.82M | -5.46M | -4.29M | -5.56M | -6.52M | -4.7M | -3.15M | -7.45M | -3.93M | -3.72M | -3.75M |
Interest Income | 11K | 1.81M | 718K | 2.58M | 81K | 258K | 294K | 318K | 199K | 333K | 172K | 79K | 45K | n/a | n/a | 51K | 72K |
Pretax Income | -3.71M | -5.97M | -3.7M | -1.84M | -5.82M | -12.58M | -7.82M | -4.91M | -3.66M | -4.39M | -6.38M | -4.85M | -3.82M | -5.85M | -3.83M | -5.88M | -3.58M |
Net Income | -3.71M | -5.97M | -3.7M | -1.84M | -5.82M | -12.58M | -7.82M | -4.91M | -2.85M | -4.39M | -6.25M | -5.01M | -4.49M | -5.85M | -3.83M | -5.88M | -3.58M |
Selling & General & Admin | 2.54M | 4.23M | 3.08M | 2.59M | 3.76M | 10.8M | 5.44M | 2.55M | 2.29M | 3.5M | 5.17M | 2.18M | 2.07M | 2.62M | 1.8M | 2.15M | 2.11M |
Research & Development | 1.08M | 1.66M | 1.44M | 1.15M | 1.95M | 3.19M | 2.73M | 2.95M | 2.05M | 2.11M | 1.37M | 2.48M | 1.04M | 2.92M | 2.01M | 1.32M | 1.42M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 15K | n/a | 328K | 255K | n/a | 328K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.63M | 5.95M | 4.52M | 3.74M | 5.71M | 13.98M | 8.17M | 5.5M | 4.34M | 5.61M | 6.54M | 4.66M | 3.11M | 5.54M | 3.81M | 3.46M | 3.54M |
Interest Expense | 124K | 132K | 202K | 179K | 72K | 634K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K | 19K | 50K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -58K | 67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.63M | 5.9M | 4.52M | 3.74M | 5.77M | 14.05M | 8.2M | 5.5M | 4.34M | 5.61M | 6.54M | 4.72M | 3.19M | 5.72M | 3.96M | 3.74M | 3.77M |
Income Tax Expense | n/a | -14.72K | n/a | n/a | 14.72K | n/a | -6K | n/a | -814K | n/a | -136K | 156K | 668K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 70.33M | 56.85M | 57.68M | 52.84M | 49.46M | 49.1M | 48.64M | 48.41M | 48.4M | 48.22M | 48.08M | 48.03M | 47.99M | 47.85M | 47.85M | 47.83M | 45.73M |
Shares Outstanding (Diluted) | 70.33M | 56.85M | 57.68M | 52.84M | 49.46M | 49.1M | 48.64M | 48.41M | 48.4M | 48.22M | 48.08M | 48.03M | 47.99M | 47.85M | 47.85M | 47.83M | 45.73M |
EPS (Basic) | -0.05 | -0.1 | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 | -0.1 | -0.06 | -0.09 | -0.13 | -0.1 | -0.09 | -0.12 | -0.08 | -0.12 | -0.08 |
EPS (Diluted) | -0.05 | -0.1 | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 | -0.1 | -0.06 | -0.09 | -0.13 | -0.1 | -0.09 | -0.12 | -0.08 | -0.12 | -0.08 |
EBITDA | -3.46M | -5.77M | -3.44M | -1.6M | -5.69M | -13.95M | -8.1M | -4.82M | -3.58M | -4.22M | -6.49M | -4.82M | -3.12M | -5.66M | -3.64M | -5.67M | -3.29M |
EBIT | -3.58M | -5.83M | -3.5M | -1.66M | -5.75M | -14M | -8.16M | -4.91M | -3.66M | -4.39M | -6.52M | -4.85M | -3.15M | -5.85M | -3.81M | -5.86M | -3.53M |
Depreciation & Amortization | 122K | 64K | 63K | 61K | 58K | 58K | 53K | 91K | 84K | 170K | 51K | 29K | 34K | 189K | 189K | 189K | 238K |